Bright Green Corp

Bright Green Corp. engages in the cultivation, manufacture, and sale of medical cannabis. It focuses on the research and development of cannabis strains and sales of products with cannabinol (CBN) and cannabigerol (CBG). The company was founded by Lynn Stockwell on April 16, 2019 and is headquartered in Fort Lauderdale, FL.

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Bright Green Corp. engages in the cultivation, manufacture, and sale of medical cannabis. It focuses on the research and development of cannabis strains and sales of products with cannabinol and cannabigerol. The company was founded by Lynn Stockwell on April 16, 2019 and is headquartered in Grants, NM.

The Company has settled a $3.6 million related party loan, representing all outstanding indebtedness, in shares of common stock and warrants, valued at $1.28 per share and accompanying warrant

Bright Green Announces Agreement to Settle Debt in Shares at a Premium

SNDL Inc.

Tilray Brands

The cannabis sector is one of the most challenging sectors in the market, leading to speculative cannabis stocks. If you've been following it for the last few years, you know the roller coaster ride investors have ridden.

High Risk, High Reward: 3 Cannabis Stocks for the Bold Trader

Bright Green has achieved several key milestones throughout the Quarter significantly advancing progress against its strategic plan, including a historic DEA Federal Registration and License Approval.

Bright Green Announces Second Quarter 2023 Financial Update and Milestone Progress

GRANTS, N.M., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or “the Company”), one of the few companies selected by the U.S. government to grow, manufacture, and sell, legally under both federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced that specific plants have now been selected for the test crops at its Grants New Mexico facility, and the company gives its operational updates.

Bright Green Operational Update

The Company plans to foster relationships with learning institutes across the U.S. to enhance the application of scientific discipline to the field of medical and pharmaceutical cannabinoid therapies and to build upon this unique EB-5 initiative for capital moving forward.

Bright Green announces plans to launch a program to support as many as 170 universities for cannabis research in the United States as well as an extension of the Company's EB-5 initiative to enable foreign students attending universities in the United States to access EB-5 visas

The Company views the development as an additional milestone building on its key strategic achievement in 2023 already including its historic DEA registration and confirmation of its EB-5 program.

Bright Green Announces it has been added to the Russell 3000® Index following the Annual Reconstitution

GRANTS, N.M., May 24, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications, and affiliated export, today announced the closing of its previously announced private placement of common stock and warrants.

Bright Green Announces Closing of $3.5 Million Private Placement

Bright Green Announces First Quarter 2023 Financial Update and Milestone Progress

Bright Green, the first publicly traded company in the U.S. to be federally authorized to grow, manufacture and sell cannabis and cannabis-related products for research, pharmaceutical and medical applications, can qualify for the EB-5 program and plans to raise $500 million in new capital

Bright Green Announces the Launch of Its EB-5 Website and Program Following the Historic Announcement of Its Federal Registration and License Approval from the U.S. Drug Enforcement Administration

Bright Green said it is the only publicly traded company to be approval to grow and sell cannabis at the federal level for research. The company said it had no revenue in the fourth quarter.

Why Shares of Bright Green Jumped Monday

Bright Green is now the first publicly traded company, and the largest, in the U.S. to be federally authorized to grow, manufacture and sell cannabis and cannabis-related products for research, pharmaceutical applications and affiliated import and export

Bright Green Announces Historic Federal Registration and License Approval from the U.S. Drug Enforcement Administration Confirming Bright Green as a Bulk Manufacturer of Cannabis

Continued investment to support long-term strategy and pathway for growth, including plans to fully acquire Alterola Biotech, appointment of Seamus McAuley as Chief Executive Officer and expansion of Scientific Advisory Board

Bright Green Announces Fourth Quarter 2022 Financial Update

Bright Green to acquire remaining 75% of Alterola common stock

Bright Green Announces Decision to Complete Alterola Biotech Acquisition

Chembio Diagnostics

Healthcare Triangle

Hepion Pharmaceuticals Inc

Hillstream Biopharma

Magenta Therapeutics Inc

Sigilon Therapeutics

Spectrum Pharma

The healthcare sector has more high return generating companies than many other sectors.

10 Best-Performing Penny Stocks in the Health Care Sector

NEW YORK , March 30, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Bright Green Corporation (NASDAQ: BGXX) resulting from allegations that Bright Green may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Bright Green securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

BGXX LOSS ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM , Encourages Bright Green Corporation Investors to Inquire About Class Action Investigation - BGXX

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Bright Green Corporation (“Bright Green” or the “Company”) (NASDAQ: BGXX) investors concerning the Company's possible violations of the federal securities laws.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Bright Green Corporation (BGXX) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Bright Green Corporation (“Bright Green” or the “Company”) (NASDAQ: BGXX) investors concerning the Company's possible violations of federal securities laws. On June 2, 2022, Green Market Report published a report alleging that Bright Green's former CEO was accusing the Company of fraud, claiming Bright Green was a “sham, operated illegally and fraudulently.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Bright Green Corporation (BGXX) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Bright Green Corporation (“Bright Green” or the “Company”) (NASDAQ: BGXX) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate.

The Law Offices of Frank R. Cruz Announces Investigation of Bright Green Corporation (BGXX) on Behalf of Investors

NEW YORK , March 10, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Bright Green Corporation (NASDAQ: BGXX) resulting from allegations that Bright Green may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Bright Green securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

TOP RANKED ROSEN LAW FIRM Encourages Bright Green Corporation Investors to Inquire About Class Action Investigation - BGXX

NEW YORK , March 2, 2023 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Bright Green Corporation (NASDAQ: BGXX) resulting from allegations that Bright Green may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Bright Green securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Bright Green Corporation Investors to Inquire About Class Action Investigation - BGXX

NEW YORK , Feb. 24, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Bright Green Corporation (NASDAQ: BGXX) resulting from allegations that Bright Green may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Bright Green securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Bright Green Corporation Investors to Inquire About Class Action Investigation - BGXX

NEW YORK , Feb. 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bright Green Corporation ("Bright Green" or the "Company") (NASDAQ: BGXX). Such investors are advised to contact Robert S.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bright Green Corporation - BGXX

NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Bright Green Corporation (“Bright Green” or the “Company”) (NASDAQ: BGXX) on behalf of Bright Green stockholders. Our investigation concerns whether Bright Green has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action.

BRIGHT GREEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Bright Green Corporation on Behalf of Bright Green Stockholders and Encourages Investors to Contact the Firm

NEW YORK , Feb. 16, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Bright Green Corporation (NASDAQ: BGXX) resulting from allegations that Bright Green may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Bright Green securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

BGXX NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Bright Green Corporation Investors to Inquire About Class Action Investigation - BGXX

ATLANTA , Feb. 16, 2023 /PRNewswire/ -- Holzer & Holzer, LLC is investigating whether Bright Green Corporation ("Bright Green" or the "Company") (NASDAQ: BGXX) complied with federal securities laws. On June 2, 2022, Green Market Report published a report detailing Bright Green's history and ongoing litigation against the Company, including a suit brought by the Company's former CEO, who is alleging that Bright Green was "a sham, operated illegally and fraudulently.

News for Bright Green Corp Stock (BGXX)